Sangram Nag

2.1k total citations
65 papers, 1.2k citations indexed

About

Sangram Nag is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Sangram Nag has authored 65 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cellular and Molecular Neuroscience, 18 papers in Molecular Biology and 15 papers in Neurology. Recurrent topics in Sangram Nag's work include Neuroscience and Neuropharmacology Research (18 papers), Medical Imaging Techniques and Applications (12 papers) and Parkinson's Disease Mechanisms and Treatments (11 papers). Sangram Nag is often cited by papers focused on Neuroscience and Neuropharmacology Research (18 papers), Medical Imaging Techniques and Applications (12 papers) and Parkinson's Disease Mechanisms and Treatments (11 papers). Sangram Nag collaborates with scholars based in Sweden, United States and Germany. Sangram Nag's co-authors include Christer Halldin, Balázs Gulyás, Andrea Varrone, Andrea Thiele, Akihiro Takano, Ryosuke Arakawa, P. Kása, Elena Pavlova, Tobias Heinrich and Georg Kettschau and has published in prestigious journals such as NeuroImage, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Sangram Nag

64 papers receiving 1.1k citations

Peers

Sangram Nag
Robert L. Gladding United States
Sofie Celen Belgium
William Trigg United Kingdom
Olivier Barret United States
Phillip Sherman United States
Sangram Nag
Citations per year, relative to Sangram Nag Sangram Nag (= 1×) peers Dai Fukumoto

Countries citing papers authored by Sangram Nag

Since Specialization
Citations

This map shows the geographic impact of Sangram Nag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sangram Nag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sangram Nag more than expected).

Fields of papers citing papers by Sangram Nag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sangram Nag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sangram Nag. The network helps show where Sangram Nag may publish in the future.

Co-authorship network of co-authors of Sangram Nag

This figure shows the co-authorship network connecting the top 25 collaborators of Sangram Nag. A scholar is included among the top collaborators of Sangram Nag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sangram Nag. Sangram Nag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cook, Brendon E., Sangram Nag, Ryosuke Arakawa, et al.. (2023). Development of a PET Tracer for OGA with Improved Kinetics in the Living Brain. Journal of Nuclear Medicine. 64(10). 1588–1593. 7 indexed citations
2.
Cselényi, Zsolt, Bengt Andrée, Jacqueline Borg, et al.. (2022). Decreased 5‐HT1A binding in mild Alzheimer's disease—A positron emission tomography study. Synapse. 76(7-8). e22235–e22235. 12 indexed citations
3.
Brumberg, Joachim, Anton Forsberg, Päivi Marjamäki, et al.. (2022). Quantification of the purinergic P2X7 receptor with [11C]SMW139 improves through correction for brain-penetrating radiometabolites. Journal of Cerebral Blood Flow & Metabolism. 43(2). 258–268. 4 indexed citations
4.
Korde, Aruna, Renata Mikołajczak, Petra Kolenc Peitl, et al.. (2022). Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals. EJNMMI Radiopharmacy and Chemistry. 7(1). 18–18. 20 indexed citations
5.
Arakawa, Ryosuke, Akihiro Takano, Per Stenkrona, et al.. (2020). PET imaging of beta-secretase 1 in the human brain: radiation dosimetry, quantification, and test-retest examination of [18F]PF-06684511. European Journal of Nuclear Medicine and Molecular Imaging. 47(10). 2429–2439. 6 indexed citations
6.
Nag, Sangram, et al.. (2019). Synthesis and biological evaluation of [18F]fluorovinpocetine, a potential PET radioligand for TSPO imaging. Bioorganic & Medicinal Chemistry Letters. 29(16). 2270–2274. 6 indexed citations
7.
Arakawa, Ryosuke, Per Stenkrona, Akihiro Takano, et al.. (2017). Test-retest reproducibility of [11C]-l-deprenyl-D2 binding to MAO-B in the human brain. EJNMMI Research. 7(1). 54–54. 21 indexed citations
8.
Delnomdedieu, Marielle, Anton Forsberg, Adam Ogden, et al.. (2017). In vivo measurement of PDE10A enzyme occupancy by positron emission tomography (PET) following single oral dose administration of PF-02545920 in healthy male subjects. Neuropharmacology. 117. 171–181. 22 indexed citations
10.
Häggkvist, Jenny, Miklós Tóth, Katarina Varnäs, et al.. (2016). Longitudinal Small-Animal PET Imaging of the zQ175 Mouse Model of Huntington Disease Shows In Vivo Changes of Molecular Targets in the Striatum and Cerebral Cortex. Journal of Nuclear Medicine. 58(4). 617–622. 14 indexed citations
11.
Nag, Sangram, Patrik Fazio, Lutz Lehmann, et al.. (2015). In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18F-Labeled Deuterated Fluorodeprenyl. Journal of Nuclear Medicine. 57(2). 315–320. 42 indexed citations
12.
Varrone, Andrea, Anton Forsberg, Akihiro Takano, et al.. (2013). In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer’s disease patients. European Journal of Nuclear Medicine and Molecular Imaging. 40(6). 921–931. 64 indexed citations
13.
Nag, Sangram, Georg Kettschau, Tobias Heinrich, et al.. (2012). Synthesis and biological evaluation of novel propargyl amines as potential fluorine-18 labeled radioligands for detection of MAO-B activity. Bioorganic & Medicinal Chemistry. 21(1). 186–195. 12 indexed citations
14.
Takano, Akihiro, Sangram Nag, Balázs Gulyás, Christer Halldin, & Lars Farde. (2011). NET occupancy by clomipramine and its active metabolite, desmethylclomipramine, in non-human primates in vivo. Psychopharmacology. 216(2). 279–286. 13 indexed citations
15.
Macauley, Matthew S. & Sangram Nag. (2011). Roth spots in pernicious anaemia. BMJ Case Reports. 2011. bcr0120113734–bcr0120113734. 5 indexed citations
16.
Nag, Sangram, et al.. (2010). Integrated care pathway for self-harm: our way forward. Emergency Medicine Journal. 27(7). 544–546. 6 indexed citations
17.
Gulyás, Balázs, Elena Pavlova, P. Kása, et al.. (2010). Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-l-deprenyl using whole hemisphere autoradiography. Neurochemistry International. 58(1). 60–68. 139 indexed citations
18.
Nag, Sangram, et al.. (2009). Blood glucose meters: old and new. Practical Diabetes International. 26(9). 362–362. 1 indexed citations
19.
Mada, Sanusi Bello, et al.. (2009). Severe acute psychosis precipitated by replacement dose hydrocortisone in newly diagnosed panhypopituitarism. 19(6). 453–62. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026